AlloRx® Stem Cells is an investigational drug derived from the Wharton's Jelly of the umbilical cord. Strict screening of the donor and medical/social history is evaluated prior to accepting cords. The cords are processed in Vitro Biopharma's ISO 7 cleanroom with strict standard operating procedures and environmental controls. Once AlloRx® Stem Cells are produced, Vitro Biopharma goes through strict quality control testing to ensure the most sterile, safe, and potent stem cells. AlloRx® Stem Cells have been used in Institutional Review Board (IRB) approved clinical trials in international countries. Vitro Biopharma receives formal letters from the Administery of Health of these countries to ensure full compliance with both domestic and international regulations.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. All information presented here is meant to educate and inform the public. Neither the Company nor its representatives are providing any medical advice, and none should be inferred, from any ideas, suggestions, or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk.